Press News and Articles

Ajan Reginald and Cell Therapy in the news / press:

Below are news and press sources featuring the latest news and developments related to Ajan Reginald and Cell Therapy Ltd

An innovative treatment for heart disease developed in Wales will be marketed in Japan after a £12m licensing deal
Wales Online

Cell Therapy Ltd. Grants Japan License to Daiichi Sankyo for its heart regeneration medicine, Heartcel™
Business Wire

Japan rights deal boosts stem cell therapy group
Financial Times

Daiichi buys Japanese rights to UK heart stem cell therapy
Reuters

Cell Therapy grants Japan license to Daiichi for heart regeneration med
FiercePharma

Cell Therapy signs £12.5 million licensing deal with Daiichi Sankyo for heart failure treatment
Pharmafile

Cell Therapy Ltd. Grants Japan License To Daiichi Sankyo For Its Heart Regeneration Medicine, Heartcel™
Pharmiweb

Cell Therapy grants Japan license to Daiichi Sankyo for Heartcel
Cardiac Rhythm News

CTL partners with Daiichi Sankyo on Heartcel
The Pharma Letter

Daiichi Sankyo: Signs License Agreement with Cell Therapy Ltd. For Heartcel
4-traders

Brief: Crowdcube success Cell Therapy receives £12.5m in Japan rights deal
Crowdfund Insider

Cell Therapy licenses heart failure therapy in Japan
PMLive

Cell Therapy Ltd’s CEO Ajan Reginald talks to TPL’s Katie Osborne
The Pharma Letter

Daiichi Sankyo licenses off-the-shelf regenerative heart cell therapy from CTL
BioPharma-Reporter

Daiichi snaps up Japanese rights to CVD stem-cell therapy
BioPharma DIVE